Hematopoetic and chills Patient Reports February 11, 2012

Hematopoetic Side Effects Report #5069282-X
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Aug 02, 2006. Male patient, weighting 79.37 lb, was diagnosed with neoplasm malignant and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: blood pressure decreased, body temperature increased, chills, heart rate increased, respiratory rate increased. Hematopoetic dosage: unknown. Patient recovered.

Hematopoetic Side Effects Report #5034879-X
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on June 23, 2006. Male patient, weighting 145.5 lb, was diagnosed with neoplasm malignant and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: body temperature increased, chills, headache , nausea . Hematopoetic dosage: unknown. Patient recovered.

Hematopoetic Side Effects Report #5041813-5
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on June 06, 2006. Female patient, weighting 141.1 lb, was diagnosed with myeloid leukaemia and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, pyrexia. Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS, NORMAL SALINE WITH KCL. Patient recovered.

Hematopoetic Side Effects Report #4893392-0
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Dec 30, 2005. Male patient, weighting 246.9 lb, was diagnosed with myelodysplastic syndrome, refractory anaemia with an excess of blasts and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, headache , infusion related reaction. Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS. Patient recovered.


Hematopoetic Side Effects Report #4826274-0
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Nov 09, 2005. Male patient, weighting 165.3 lb, was diagnosed with myelodysplastic syndrome and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, muscle tightness. Hematopoetic dosage: unknown. Patient recovered.

Hematopoetic Side Effects Report #4955285-X
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Feb 24, 2006. Female patient, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: back pain , chills, flank pain, infusion related reaction, nausea . Hematopoetic dosage: unknown. Patient recovered.

Hematopoetic Side Effects Report #4775624-2
Hematopoetic side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 20, 2005. Male patient, weighting 5.05 lb, was diagnosed with multiple myeloma  and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: abdominal pain , blood creatinine increased, blood culture positive, chills, complications of transplant surgery, depressed level of consciousness, diarrhoea, haemoglobin decreased, hyperkalaemia. Hematopoetic dosage: unknown. During the same period patient was treated with CELEBREX, TACROLIMUS, AUTOLOGOUS TRANSPLANT. Patient was hospitalized. Patient recovered.

Hematopoetic Side Effects Report #4826267-3
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Nov 09, 2005. Female patient, weighting 202.8 lb, was diagnosed with leukaemia plasmacytic and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: blood pressure decreased, chills, infusion related reaction, pyrexia, vomiting, wheezing. Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS. Patient recovered.

Hematopoetic Side Effects Report #4820164-5
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2005. Male patient, weighting 163.1 lb, was diagnosed with hodgkin's disease  and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, flushing, headache , infusion related reaction, nausea , procedural complication. Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS. Patient recovered.


Hematopoetic Side Effects Report #4873249-1
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Dec 29, 2005. Male patient, weighting 211.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, nausea . Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS. Patient recovered.

Hematopoetic Side Effects Report #4838069-2
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Nov 04, 2005. Male patient, weighting 211.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, nausea . Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS. Patient recovered.

Hematopoetic Side Effects Report #4953048-2
Hematopoetic side effect was reported by a Health Professional from UNITED STATES on Feb 17, 2006. Female patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Hematopoetic. After drug was administered, patient experienced the following side effects: chills, nausea . Hematopoetic dosage: unknown. During the same period patient was treated with HEMATOPOETIC PROGENITOR CELLS. Patient recovered.